Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TATAA Biocenter Introduces Ingenuity Systems iReport into qPCR Workflow

Published: Wednesday, January 23, 2013
Last Updated: Wednesday, January 23, 2013
Bookmark and Share
TATAA Biocenter, Europe´s leading provider of genomic services using quantitative real-time polymerase PCR (qPCR), is complementing its offerings in high-throughput gene expression profiling with Ingenuity® iReport™.

TATAA Biocenter  is complementing its offerings in high-throughput gene expression profiling with Ingenuity® iReport™. The combined solution enables TATAA Biocenter's laboratories to provide contract research for a full range of real-time qPCR services, including primer and probe design, validation, kit and instrument evaluation, and biological and statistical analysis to academic, pharmaceutical and biotech companies world-wide.


TATAA Biocenter offers a seamless workflow, with all of the instrumentation and sample handing necessary for performing high quality qPCR experiments, and meets the specific requirements for compliance with ISO 17025. Ingenuity iReport enables researchers to quickly and easily identify significant differentially expressed genes and interpret the impact of those expression changes in the context of pathways, phenotypes and molecular interactions.


“The combination of Ingenuity iReport with TATAA Biocenter’s expertise opens up an exciting opportunity for researchers to get access to a complete qPCR workflow,” stated Bryant Macy, SVP Products and Marketing of Ingenuity Systems. “By providing a complete end-to-end workflow including access to iReport, TATAA is enabling researchers to quickly understand the biological meaning of their expression data.”


“The goal of an expression profiling study is to learn the underlying biology. By introducing Ingenuity iReport into our workflow, we are the first service provider to offer experimental design, nucleic acid extraction, QC, profiling, biostatistical and pathways analyses,” says Dr. Mikael Kubista, founder and CEO of TATAA Biocenter. “After thorough evaluation of the various alternatives for pathway analysis available, we decided on iReport, since it provides a smooth workflow with data collected on our OpenArray and BioMark high throughput qPCR platforms, reads batch-wise into GenEx software for multivariate statistical analysis, and provides an easy, accurate, web-based biological and statistical interpretation tool.”

For more information see www.tataa.com or contact us on info@tataa.com


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
FNIH Launches Project to Evaluate Biomarkers in Cancer Patients
Company has announced that it has launched a new project to evaluate the effectiveness of liquid biopsies as biomarkers in colorectal cancer patients.
Drugs that May Combat Deadly Antibiotic-Resistant Bacteria Uncovered
Study identifies 79 compounds that inhibit carbapenem-resistant Enterobacteriaceae (CRE).
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!